Detalhe da pesquisa
1.
Secretion of matrix metalloproteinases and their inhibitors (tissue inhibitor of metalloproteinases) by human prostate in explant cultures: reduced tissue inhibitor of metalloproteinase secretion by malignant tissues.
Cancer Res
; 53(19): 4493-8, 1993 Oct 01.
Artigo
Inglês
| MEDLINE | ID: mdl-7691397
2.
Identification of bladder tumor-derived hyaluronidase: its similarity to HYAL1.
Cancer Res
; 59(17): 4464-70, 1999 Sep 01.
Artigo
Inglês
| MEDLINE | ID: mdl-10485499
3.
Extracellular collagenase, proteoglycanase and products of their activity, released in organ culture by intact dermal inflammatory lesions produced by sulfur mustard.
J Invest Dermatol
; 95(6): 717-26, 1990 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-2174450
4.
Inhibition of prostate cancer metastasis in vivo: a comparison of 1,23-dihydroxyvitamin D (calcitriol) and EB1089.
Cancer Epidemiol Biomarkers Prev
; 8(3): 241-8, 1999 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-10090302
5.
Regulation of MMP-9 activity in human tear fluid and corneal epithelial culture supernatant.
Invest Ophthalmol Vis Sci
; 41(7): 1703-9, 2000 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-10845589
6.
CMT-3, a chemically modified tetracycline, inhibits bony metastases and delays the development of paraplegia in a rat model of prostate cancer.
Ann N Y Acad Sci
; 878: 678-82, 1999 Jun 30.
Artigo
Inglês
| MEDLINE | ID: mdl-10415806
7.
Two latent metalloproteases of human articular cartilage that digest proteoglycan.
J Biol Chem
; 259(6): 3633-8, 1984 Mar 25.
Artigo
Inglês
| MEDLINE | ID: mdl-6368548
8.
Differences in hyaluronic acid-mediated functions and signaling in arterial, microvessel, and vein-derived human endothelial cells.
J Biol Chem
; 275(36): 27641-9, 2000 Sep 08.
Artigo
Inglês
| MEDLINE | ID: mdl-10882722
9.
The association of elevated urinary total to sulfated glycosaminoglycan ratio and high molecular mass hyaluronic acid with interstitial cystitis.
J Urol
; 163(5): 1577-83, 2000 May.
Artigo
Inglês
| MEDLINE | ID: mdl-10751891
10.
Potential application of a chemically modified non-antimicrobial tetracycline (CMT-3) against metastatic prostate cancer.
Adv Dent Res
; 12(2): 97-102, 1998 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-9972130